Overcoming resistance to single-agent therapy for oncogenic BRAF gene fusions via combinatorial targeting of MAPK and PI3K/mTOR signaling pathways

MLA

Angela J. Waanders, et al. “Overcoming Resistance to Single-Agent Therapy for Oncogenic BRAF Gene Fusions via Combinatorial Targeting of MAPK and PI3K/MTOR Signaling Pathways.” Oncotarget, vol. 8, Sept. 2017, pp. 84697–713. EBSCOhost, https://doi.org/10.18632/oncotarget.20949.

APA

Angela J. Waanders, Daphne A. Haas-Kogan, Payal Jain, Phillip B. Storm, Aleksandra Olow, Shih-Shan Lang, Tiffany Smith, Christine Busch, Sabine Mueller, Elizabeth Fox, Aesha Vakil, Xiaodong Yang, Amanda Silva, Adam C. Resnick, Namrata Choudhari, Pichai Raman, Harry J. Han, Yuankun Zhu, Tim Delaney, … Katie Boucher. (2017). Overcoming resistance to single-agent therapy for oncogenic BRAF gene fusions via combinatorial targeting of MAPK and PI3K/mTOR signaling pathways. Oncotarget, 8, 84697–84713. https://doi.org/10.18632/oncotarget.20949

Chicago

Angela J. Waanders, Daphne A. Haas-Kogan, Payal Jain, Phillip B. Storm, Aleksandra Olow, Shih-Shan Lang, Tiffany Smith, et al. 2017. “Overcoming Resistance to Single-Agent Therapy for Oncogenic BRAF Gene Fusions via Combinatorial Targeting of MAPK and PI3K/MTOR Signaling Pathways.” Oncotarget 8 (September): 84697–713. doi:10.18632/oncotarget.20949.